Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emergent BioSolutions is a global life sciences company focused on providing preparedness and response solutions for public health threats. The company is a leading provider of medical countermeasures for biological threats, including anthrax, smallpox, and botulism, and manufactures the widely used opioid overdose reversal agent Narcan (naloxone HCl) nasal spray. Emergent also operates a significant contract development and manufacturing organization (CDMO) that supports the production of complex biologics and vaccines for other pharmaceutical companies. Headquartered in Gaithersburg, Maryland, the company maintains a strategic partnership with the U.S. government to ensure the availability of critical treatments for national security and public health emergencies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emergent Group.